From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?-Reference-Cited by-同舟云学术

From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?

Published:2016-05-06 Issue:17 Volume:59 Page:7759-7770
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bolognesi Maria Laura¹,Gandini Annachiara¹²,Prati Federica¹³,Uliassi Elisa¹

Affiliation:

1. Department of Pharmacy and Biotechnology, Alma Mater Studiorum—University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy

2. Department of Neuroscience, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Via Bonomea 265, I-34136 Trieste, Italy

3. College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee DD1 5EH, U.K.

Funder

Università di Bologna

Ricerca Fondamentale Orientata, Università di Bologna

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00151

Reference86 articles.

1. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

2. World Alzheimer Report 2015: The global impact of dementia, Alzheimer’s Disease International 2015.http://www.alz.co.uk/research/statistics(accessed Jan 20, 2016) .

3. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

4. Biomedicine wins big in US budget deal

5. Amyloid Chemical Probes and Theranostics: Steps Toward Personalized Medicine in Neurodegenerative Diseases

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailored therapies: Exploring macromolecule based delivery science for personalized medicine;Journal of Macromolecular Science, Part B;2024-06-29

2. Recent Advances in Fluorescent Theranostics for Alzheimer’s Disease: A Comprehensive Survey on Design, Synthesis, and Properties;ACS Omega;2024-03-11

3. Drug Discovery Based on Oxygen and Nitrogen (Non-)Heterocyclic Compounds Developed @LAQV–REQUIMTE/Aveiro;Pharmaceuticals;2023-11-30

4. Small-molecule theranostics in Alzheimer's disease;European Journal of Medicinal Chemistry;2023-07

5. Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease;Antioxidants & Redox Signaling;2023-02-23